RAMIVEN 50MG

Ramiven 50 mg Tablet is classified as an anti-cancer medication known as a kinase inhibitor, utilized either alone or in conjunction with other anti-cancer therapies to address specific forms of breast cancer. Breast cancer occurs when breast cells begin to grow abnormally.

The active ingredient in Ramiven 50 mg Tablet is Abemaciclib, which functions by inhibiting cyclin-dependent kinase 4 and 6 proteins essential for cell growth and division. This action effectively slows the proliferation of cancer cells and hinders the advancement of the disease.

It is important to take Ramiven 50 mg Tablet according to the dosage and duration recommended by your healthcare provider. Common side effects associated with Ramiven 50 mg Tablet may include nausea, diarrhea, abdominal discomfort, and fatigue. Most of these effects are not serious and typically resolve on their own over time. However, if these symptoms persist, it is advisable to consult your doctor.

Do not use Ramiven 50 mg Tablet if you are pregnant or nursing. This medication may induce dizziness, so it is recommended to drive only when you feel fully alert. Ramiven 50 mg Tablet is not suitable for children, as its safety and efficacy have not been confirmed in this age group. Additionally, avoid alcohol consumption while taking Ramiven 50 mg Tablet, as it may exacerbate dizziness. Prior to starting Ramiven 50 mg Tablet, inform your physician about your medical history and any other medications you are taking to prevent potential side effects.